Skip to content

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence

Automatic Segmentation of Mediastinal Lymph Nodes and Blood Vessels in Endobronchial Ultrasound (EBUS) Images Using a Deep Neural Network

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05739331
Enrollment
50
Registered
2023-02-22
Start date
2023-05-01
Completion date
2027-12-01
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Endobronchial Ultrasound, Lung Cancer

Brief summary

To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.

Detailed description

Multi-center prospective feasibility study. The DNN model will be trained on ultrasound images with annotation to identifies lymph nodes and blood vessels examined with EBUS. The ability of the DNN to segment lymph nodes and vessels based on postoperative processing and static EBUS images will be evaluated in the first part of the study. In the second part of the study Real-time use of DNN in EBUS procedure will be evaluated.

Interventions

Machine learning algorithm run on EBUS images for real-time labelling of mediastinal lymph nodes and lymph node level

Sponsors

Helse Nord-Trøndelag HF
CollaboratorOTHER
SINTEF Health Research
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects referred to thoracic department in any of the participating hospitals with undiagnosed enlarged mediastinal and hilar lymph nodes. * Subjects have to be ≥ 18 years of age

Exclusion criteria

* Pregnancy * Any patient that the Investigator feels is not appropriate for this study for any reason.

Design outcomes

Primary

MeasureTime frameDescription
Capability8 monthsTo explore if Deep neural network (DNN) has capability to segment lymph nodes and blood vessels from EBUS images

Secondary

MeasureTime frameDescription
Sensitivity2 monthsTrue positive rate. Correctly detected lymph nodes/blood vessel over total lymph nodes/blood vessel. Measured per pixel in the EBUS images
Specificity2 monthsSpecificity = (True Negative)/(True Negative + False Positive). Measured per pixel in the EBUS images.
Precision2 monthsThe precision the DNN has for detecting lymph nodes and blood vessels. Measured both per voxel in the EBUS images and per annotated structure (a structure is counted as detected if at least 50% of its annotated pixels are identified by the DNN).
Run-time2 monthsIs the run-time sufficiently low for real-time analysis during EBUS?
Adverse events48 hoursProcedure related adverse events or unexpected incidents registered
Dice similarity coefficient2 monthsMeasures the similarity between two sets of data: Annotated by pulmonologist vs DNN.

Countries

Norway

Contacts

Primary ContactØyvind Ervik, MD
oyvind.ervik@ntnu.no+4791634595
Backup ContactHanne Sorger, MD,PhD
hanne.sorger@ntnu.no+4791816787

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026